Effects of hyperimmune equine plasma on clinical and cellular responses in a low-dose endotoxaemia model in horses

Research in Veterinary Science

Volumn 92, Issue 1, 2012, Pages 40-44

  Forbes, G ^a   Church, S ^a   Savage, C J ^a   Bailey, S R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Endotoxaemia; Equine; Hyperimmune plasma; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EQUIPLAS; HYPERIMMUNE GLOBULIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ENDOTOXEMIA; ESCHERICHIA COLI; HORSE; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; CROSS-OVER STUDIES; ENDOTOXEMIA; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; FEMALE; HORSE DISEASES; HORSES; IMMUNIZATION, PASSIVE; LEUKOCYTE COUNT; LEUKOCYTES; PLASMA; TUMOR NECROSIS FACTOR-ALPHA;

EQUIDAE; ESCHERICHIA COLI;

EID: 83955164325     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.10.020     Document Type: Article

References (33)

1. Allen G.K., Campbell-Beggs C., Robinson J.A., Johnson P.J., Green E.M. Induction of early-phase endotoxin tolerance in horses. Equine Veterinary Journal 1996, 28:269-274.
2. Armstrong S., Lees P. Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-α by equine chondrocytes and synoviocytes. Journal of Veterinary Pharmacology and Therapeutics 2002, 25:145-153.
3. Baskett A., Barton M.H., Norton N., Anders B., Moore J.N. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. American Journal of Veterinary Research 1997, 58:1291-1299.
4. Beeler-Marfisi J., Clark M.E., Wen X., Sears W., Huber L., Ackerley C., Viel L., Bienzle D. Experimental induction of recurrent airway obstruction with inhaled fungal spores, lipopolysaccharide, and silica microspheres in horses. American Journal of Veterinary Research 2010, 71:682-689.
5. Bryant C.E., Spring D.R., Gangloff M., Gay N.J. The molecular basis of the host response to lipopolysaccharide. National Review of Microbiology 2010, 8:8-14.
6. Chaiyotwittayakun A., Burton J.L., Weber P.S.D., Kizilkaya K., Cardoso F.F., Erskine R.J. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous Gram-negative bacteria. Journal of Dairy Science 2004, 87:3375-3385.
7. Coté N., Trout D.R., Hayes A.M. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs. Canadian Journal of Veterinary Research 1996, 60:150-157.
8. Durando M.M., MacKay R.J., Linda S., Skelley L.A. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. American Journal of Veterinary Research 1994, 55:921-927.
9. Figueiredo M.D., Moore J.N., Vandenplas M.L., Sun W.C., Murray T.F. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in equine whole blood and monocytes. American Journal of Veterinary Research 2008, 69:796-803.
10. Flohé S., Dominguez Fernández E., Ackermann M., Hirsch T., Börgermann J., Schade F.U. Endotoxin tolerance in rats: expression of TNF-alpha, IL-6, IL-10, VCAM-1 AND HSP 70 in lung and liver during endotoxin shock. Cytokine 1999, 11:796-804.
11. Frellstedt L., Furr M.O. Endotoxin tolerance induced in vitro in equine lymphocytes (Abstract #127). Journal of Veterinary Internal Medicine 2010, 24:709-710.
12. Freudenberg M.A., Fomsgaard A., Mitov I., Galanos C. ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens. Infection 1989, 17:322-328.
13. Gaffin S.L., Wells M.T. A morphological study of the action of equine anti-lipopolysaccharide plasma on gram-negative bacteria. Journal of Medical Microbiology 1987, 24:165-168.
14. Garner H.E., Sprouse R.F., Lager K. Cross protection of ponies from sublethal Escherichia coli endotoxemia by Salmonella typhimurium antiserum. Equine Practice 1988, 10:10-17.
15. Kotiw M., Raghaven C., Johnson M., Shiels I.A., Wilson R.P. The effect of equine hyperimmune sera on TNFα activity in a L929 cell bioassay. Proceedings of Australian Equine Science Symposium 2006, 1:22-23.
16. Kotiw M., Morgan M., Taylor S.M., Shiels I.A. Detection of anti-TNFalpha activity in canine hyperimmune serum using a TNFalpha inhibition assay. Veterinary Clinical Pathology 2010, 39:46-52.
17. McCallus D.E., Norcross N.L. Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time. Infection and Immunity 1987, 55:1042-1046.
18. Menzies-Gow N., Bailey S.R., Katz L.M., Marr C.M., Elliott J. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Veterinary Journal 2004, 36:273-278.
19. Menzies-Gow N.J., Bailey S.R., Stevens K., Katz L., Elliott J., Marr C.M. Digital blood flow and plasma endothelin concentration in clinically endotoxemic horses. American Journal of Veterinary Research 2005, 66:630-636.
20. Menzies-Gow N.J., Sepulveda M.F., Bailey S.R., Cunningham F.M., Elliott J. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses. American Journal of Veterinary Research 2008, 69:199-207.
21. Moore J.N. Recognition and treatment of endotoxemia. Veterinary Clinics of North America Equine Practice 1988, 4:105-113.
22. Moore J.N., Barton M.H. Treatment of endotoxemia. Veterinary Clinics of North America Equine Practice 2003, 19:681-695.
23. Morris D., Whitlock R. Therapy of suspected septicemia in neonatal foals using plasma-containing antibodies to core lipopolysaccharide (LPS). Journal of Veterinary Internal Medicine 1987, 1:175-182.
24. Morris D.D., Whitlock R.H., Corbeil L.B. Endotoxemia in horses: protection provided by antiserum to core lipopolysaccharide. American Journal of Veterinary Research 1986, 47:544-550.
25. Peek S.F., Riseberg N., Laura S.M., Coombs F., Slack A., Semrad J.A., McGuirk D., Keuler S., Marques L. Prognostic value of clinicopathologic variables obtained at admission and effect of antiendotoxin plasma on survival in septic and critically ill foals. Journal of Veterinary Internal Medicine 2006, 20:569-574.
26. Poulin Braim A.E., MacDonald M.H., Bruss M.L., Grattendick K.J., Giri S.N., Margolin S.B. Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia. American Journal of Veterinary Research 2009, 70:1031-1042.
27. Siber G.R., Kania S.A., Warren H.S. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other Gram-negative bacteria. Journal of Infectious Diseases 1985, 152:954-964.
28. Spier S.J., Smith J.S., Snyder W.M., Lavoie B.P., Cullor J.R., Sischo J.P. Protection against clinical endotoxemia in horses by using plasma containing antibody to an Rc mutant E. coli (J5). Circulatory Shock 1989, 28:235-237.
29. Tóth F., Frank N., Chameroy K.A., Boston R.C. Effects of endotoxaemia and carbohydrate overload on glucose and insulin dynamics and the development of laminitis in horses. Equine Veterinary Journal 2009, 41:852-858.
30. Vick M.M., Adams A.A., Murphy B.A., Sessions D.R., Horohov D.W., Cook R.F., Shelton B.J., Fitzgerald B.P. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. Journal of Animal Science 2007, 85:1144-1155.
31. Wells M.T., Coovadia M., Gaffin Y., Gregory S.L. Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria. Journal of Medical Microbiology 1987, 24:187.
32. Werners A.H., Bull S., Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Veterinary Journal 2005, 37:371-383.
33. Ziegler E.J., McCutchan J.A., Fierer J., Glauser M.P., Sadoff J.C., Douglas H., Braude A.I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. New England Journal of Medicine 1982, 307:1225-1230.